Research paperSynthesis and evaluation of colletoic acid core derivatives
Graphical abstract
Section snippets
Competing interests
The authors declare that they have no competing interests.
Acknowledgments
This study was supported by the American Lebanese Syrian Associated Charities (ALSAC). The authors thank the High-Throughput Analytical Chemistry Core Facility, the cell sorting facility, and the Protein production facility at St. Jude Children's Research Hospital, for technical assistance.
References (22)
Noble metal hydroxides on carbon nonpyrophoric dry catalysts
Tetrahedron Lett.
(1967)- et al.
The influence of drug-like concepts on decision-making in medicinal chemistry
Nat. Rev. Drug Discov.
(2007) - et al.
Crystal structures of 11β-hydroxysteroid dehydrogenase type 1 and their use in drug discovery
Future Med. Chem.
(2011) - et al.
Natural products as sources of new drugs over the 30 years from 1981 to 2010
J. Nat. Prod.
(2012) - et al.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
(2004)Diabetes Public Health Resource
et al.Metabolic syndrome as a predictor of type 2 diabetes and its clinical interpretations and usefulness
J. Diabetes Investig.
(2013) - et al.
Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose and skeletal muscle tissues in vivo
Diabetes
(2012) - et al.
Altered activity of 11β-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes
J. Clin. Endocrinol. Metab.
(2007) - et al.
Cortisol effects on body mass, blood pressure, and cholesterol in the general population
Hypertension
(1999)et al.Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats
PLoS One
(2013) - et al.
11-β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
J. Exp. Med.
(2005)et al.Selective inhibition of 11 β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycemic mice
Diabetologia
(2002) - et al.
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
Proc. Natl. Acad. Sci. USA.
(1997)et al.Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Am. J. Physiol. Regul. Integr. Comp. Physiol.
(2005)et al.Inhibition of 11β-HSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice
BMC Pharmacol.
(2008)
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
Diabetes Obes. Metab.
(2011)
et al.11β-Hydroxysteroid dehydrogenase type 1 activity biomarkers and pharcokinetics of PF-00915275, a selective 11β-HSD1 inhibitor
J. Clin. Endocrinol. Metab.
(2008)
et al.Effects of the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
J. Clin. Endocrinol. Metab.
(2003)
Cited by (0)
Copyright © 2016 Elsevier Masson SAS. All rights reserved.